Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019
暂无分享,去创建一个
M. Naghavi | F. Farzadfar | B. Larijani | M. Keykhaei | S. Saeedi Moghaddam | N. Rezaei | N. Rezaei | Parnian Shobeiri | S. A. Nejadghaderi | Sahar Saeedi Moghaddam
[1] H. Fallahzadeh,et al. Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study , 2022, BMC Nephrology.
[2] Ali Kazemi Karyani,et al. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet.
[3] F. Farzadfar,et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions , 2021, PloS one.
[4] F. Farzadfar,et al. Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans , 2021, Journal of Diabetes & Metabolic Disorders.
[5] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[6] Dan J Stein,et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[7] H. Fallahzadeh,et al. Comparison of Sleep patterns in Menopausal and Non-menopausal Women: Results of the First Phase of Shahedieh Cohort Study , 2020 .
[8] F. Farzadfar,et al. Patterns of Obesity and Overweight in the Iranian Population: Findings of STEPs 2016 , 2020, Frontiers in Endocrinology.
[9] A. Ghanbarzadegan,et al. Ranking of Iranian provinces based on healthcare infrastructures: before and after implementation of Health Transformation Plan , 2020, Cost Effectiveness and Resource Allocation.
[10] L. G. Vu,et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.
[11] F. Farzadfar,et al. Physical activity profile of the Iranian population: STEPS survey, 2016 , 2019, BMC Public Health.
[12] M. Yaseri,et al. Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline , 2019, Medical journal of the Islamic Republic of Iran.
[13] M. Dabbaghmanesh,et al. A Population-Based Study on the Prevalence and Risk Factors of Chronic Kidney Disease in the Adult Population of Shiraz, Southern Iran , 2019, Galen medical journal.
[14] C. Thongprayoon,et al. Association between urologic malignancies and end‐stage renal disease: A meta‐analysis , 2018, Nephrology.
[15] J. Valdivielso,et al. Sex hormones and their influence on chronic kidney disease , 2019, Current opinion in nephrology and hypertension.
[16] F. Azizi,et al. Dietary pattern and incidence of chronic kidney disease among adults: a population-based study , 2018, Nutrition & Metabolism.
[17] F. Farzadfar,et al. Salt intake among Iranian population: the first national report on salt intake in Iran , 2018, Journal of hypertension.
[18] A. Maxwell,et al. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England , 2018, PloS one.
[19] Hong Xian,et al. Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016 , 2018, JAMA network open.
[20] H. Dargahi,et al. Patients’ complaints before and after implementation of health transformation plan , 2018 .
[21] M. Hesaraki,et al. Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta‐Analysis and Systematic Review , 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[22] S. Khodakarim,et al. Urban-Rural Differences in the Prevalence of Self-Reported Diabetes and its Risk Factors: The WHO STEPS Iranian Noncommunicable Disease Risk Factor Surveillance in 2011 , 2017, Iranian journal of medical sciences.
[23] R. Malekzadeh,et al. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study , 2017, PloS one.
[24] H. Najafipour,et al. Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City , 2017 .
[25] 藤倉雄二,et al. わが国における成人市中肺炎の原因微生物の変遷(Meta‐analysis and systematic review) , 2017 .
[26] T. Vos,et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.
[27] M. Sayadi,et al. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. , 2014, Iranian journal of kidney diseases.
[28] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[29] Kai-Uwe Eckardt,et al. Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.
[30] R. Malekzadeh,et al. Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. , 2012, Archives of Iranian medicine.
[31] M. Amini,et al. Distribution of albuminuria and low glomerular filtration rate in a rural area, Shahreza, Iran. , 2011, Iranian journal of kidney diseases.
[32] R. Malekzadeh,et al. Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran , 2010, PloS one.
[33] M. Tonelli,et al. Population based screening for chronic kidney disease: cost effectiveness study , 2010, BMJ : British Medical Journal.
[34] S. Hatami,et al. Screening for asymptomatic kidney disease in high-risk population of Urmia, Iran. , 2010, Iranian journal of kidney diseases.
[35] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[36] M. Mahdavi-Mazdeh,et al. Screening for Decreased Renal Function in Taxi Drivers in Tehran, Iran , 2010, Renal failure.
[37] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[38] P. Mitchell,et al. Association of CKD and cancer risk in older people. , 2009, Journal of the American Society of Nephrology : JASN.
[39] F. Azizi,et al. High prevalence of chronic kidney disease in Iran: a large population-based study , 2009, BMC public health.
[40] M. Mahdavi-Mazdeh,et al. Burden of chronic kidney disease in Iran: a screening program is of essential need. , 2008, Iranian journal of kidney diseases.
[41] F. Schmidt. Meta-Analysis , 2008 .
[42] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[43] J. McGill,et al. Kidney Early Evaluation Program (KEEP) , 2004, The Diabetes educator.
[44] M. Klag,et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.